-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Ardent Health with Buy Rating, Announces Price Target of $17

Benzinga·09/10/2025 10:47:14
Listen to the news
UBS analyst A.J. Rice initiates coverage on Ardent Health (NYSE:ARDT) with a Buy rating and announces Price Target of $17.